CompletedPhase 1NCT05541861
Safety and Effects of an Investigational COVID-19 Vaccine as Booster in Healthy People
Studying Severe acute respiratory syndrome
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- BioNTech SE
- Principal Investigator
- BioNTech Responsible PersonBioNTech SE
- Intervention
- BNT162b2 Bivalent (original/Omicron BA.4/BA.5) 30 mcg(biological)
- Enrollment
- 383 target
- Eligibility
- 18 years · All sexes
- Timeline
- 2022 – 2024
Study locations (17)
- Alliance for Multispecialty Research, LLC, Tempe, Arizona, United States
- Hoag Hospital, Newport Beach, California, United States
- California Research Foundation, San Diego, California, United States
- Diablo Clinical Research, Inc., Walnut Creek, California, United States
- Clinical Research Consulting, LLC, Milford, Connecticut, United States
- Cenexel RCA (Research Centers of America), Hollywood, Florida, United States
- Research Institute of South Florida, Inc., Miami, Florida, United States
- Great Lakes Clinical Trials LLC - Andersonville, Chicago, Illinois, United States
- Johnson County Clin-Trials, Inc. (JCCT), Lenexa, Kansas, United States
- University of Kentucky Center for Clinical and Translational Science (outpatient clinic), Lexington, Kentucky, United States
- Alliance for Multispecialty Research, LLC (Kansas), Kansas City, Missouri, United States
- Finger Lakes Clinical Research, Rochester, New York, United States
- CTI Clinical Research Center, Cincinnati, Ohio, United States
- Alliance for Multispecialty Research, LLC, Knoxville, Tennessee, United States
- Clinical Trials of Texas, LLC / Flourish Research, San Antonio, Texas, United States
- +2 more locations on ClinicalTrials.gov
Collaborators
Pfizer
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT05541861 on ClinicalTrials.govOther trials for Severe acute respiratory syndrome
Additional recruiting or active studies for the same condition.
- RECRUITINGNANCT06099795Evaluation of Concordance Between Exhaled Air Test (eBAM-CoV) and RT-PCR to Detect SARS-CoV-2Centre Hospitalier Universitaire de Nīmes
- RECRUITINGPHASE4NCT06585241A Study to Investigate the Immunogenicity and Safety of mRNA COVID-19 Variant-containing Vaccine FormulationsModernaTX, Inc.
- RECRUITINGNCT06168019Influenza & COVID-19 Obstetric and Perinatal Epidemiology Study in IndiaBoston University
- RECRUITINGEARLY PHASE1NCT05656105Positron Emission Tomography (PET) Imaging of Neuroinflammation in Patients With Neurological Dysfunction After Severe Acute Respiratory Syndrome Coronavirus 2 (SARS CoV 2) InfectionUniversity of Alabama at Birmingham
- RECRUITINGNCT05892549COVID-19: Early Detection of Worsening by Voice and Respiratory Pattern CharacteristicsDirection Centrale du Service de Santé des Armées
- RECRUITINGNANCT05566483Physiology of Long COVID-19 and the Impact of Cardiopulmonary Rehabilitation on Quality-of-Life and Functional CapacityUniversity of Colorado, Denver
- ACTIVE NOT RECRUITINGNCT05787964Immunity to Infection in Healthy Participants and Participants With CancerUniversity Hospital Tuebingen
- RECRUITINGPHASE2, PHASE3NCT05543616A Study to Learn About Variant-Adapted COVID-19 RNA Vaccine Candidate(s) in Healthy ChildrenBioNTech SE